Sector consensus Bayer AG

Equities

Market Closed - Xetra Other stock markets 16:35:45 08/05/2026 BST			5-day change	1st Jan Change
36.98 ^EUR	-1.20%		-2.81%	-0.08%

05-08	BAYER AG : UBS maintains a Buy rating	ZD
05-08	UBS maintains 'Buy' rating on Bayer - Target 52 euros	DP

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
BAYER AG	48.47	+31.08%	19
ELI LILLY AND COMPANY	1,209.14	+27.49%	29
JOHNSON & JOHNSON	252.42	+14.05%	24
ABBVIE INC.	252.23	+25.15%	30
ROCHE HOLDING AG	360.76	+14.42%	17
ASTRAZENECA PLC	221.63	+21.89%	21
NOVARTIS AG	155.32	+6.53%	21
MERCK & CO., INC.	129.74	+16.48%	27
NOVO NORDISK A/S	307.34	+5.87%	23
AMGEN INC.	353.07	+6.44%	30
GILEAD SCIENCES, INC.	158.07	+20.36%	28
PFIZER INC.	29.11	+13.37%	27
BRISTOL-MYERS SQUIBB COMPANY	63.32	+12.75%	25
VERTEX PHARMACEUTICALS INCORPORATED	549.5	+27.84%	28
SANOFI	97.1	+32.83%	23
GSK PLC	20.3	+10.15%	20
CHUGAI PHARMACEUTICAL CO., LTD.	10,136.67	+28.31%	15
TAKEDA PHARMACEUTICAL COMPANY LIMITED	6,036.87	+15.8%	15
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	80.38	+52.24%	17
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	40.27	+12.71%	11
Average	1,025.09	+19.79%	22
Weighted average by Cap.	678.54	+18.94%	25